13G Filing: Armistice Capital and Vanda Pharmaceuticals Inc. (VNDA)

Page 10 of 10

Page 10 of 10 – SEC Filing

Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13G dated June 19, 2017 relating to the Common Stock, $0.001 par value per share, of Vanda Pharmaceuticals Inc. shall be filed on behalf of the undersigned.
Armistice Capital, LLC
By:  /s/ Steven Boyd                      
Steven Boyd
Managing Member
Armistice Capital Master Fund Ltd.
By:  /s/ Steven Boyd                       
Steven Boyd
Director
/s/  Steven Boyd                             
Steven Boyd

Follow Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Page 10 of 10